뒤로
TYK Medicines, Inc(02410.HK) 가격
02410.HK 주가 차트
TYK MEDICINES-B (02410.HK)
TYK Medicines, Inc
HK$13.43
-0.51%
$-0.07
정규장: Jan 19, 11:03:28 HKT
주요 통계
이전 종가
$13.56
시가
$13.5
일일 범위
$13.26 - $13.57
52주 범위
$12.1 - $46.1
거래량
587.0K
평균 거래량
3.3M
EPS(TTM)
-0.84
배당수익률
--
시가총액
$5.0B
TYK MEDICINES-B란 무엇인가요?
TYK Medicines, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in Shanghai, Shanghai and currently employs 163 full-time employees. The company went IPO on 2024-08-20. The firm is primarily focused on small molecule drug development, and its main products include TY-9591, TY-302 and TY-2136. TY-9591 is a third-generation EGFR-TKI with antitumor effects on EGFR mutations. TY-302 is a potent, selective oral CDK4/6 inhibitor developed for the treatment of advanced solid tumors, including breast cancer and prostate cancer. TY-2136b is an internally developed, oral ROS1/NTRK inhibitor for the treatment of solid tumors.
